Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients

Clinical trial NCT04898270 · COMPLETED

Trial details

NCT number: NCT04898270
Sponsor: Taichung Veterans General Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia; Psychosis Metabolic Syndrome Flupentixol Antipsychotic Agents Central Nervous System Diseases Clinical Therapy Olanzapine Quetiapine

Start date: 2019-12-19
Primary completion: 2020-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.